ARPA-H funds $160 million gene-editing push for rare diseases after administrative delays
The U.S. Advanced Research Projects Agency for Health (ARPA-H) is awarding $160 million to seven research laboratories to accelerate development…
Editor's Top Picks
mRNA Cancer Vaccines Harness Unexpected Immune Backup System, Study Finds
Researchers have identified an unexpected immune cell type recruited by mRNA cancer vaccines, challenging conventional understanding and potentially enabling more…
Submit Your Paper to GMJ
Psychedelic Therapies at the Threshold: Why Rigorous Surveillance Must Precede Market Access
As psychedelic therapies approach FDA approval, medical journals and regulators must establish rigorous post-market surveillance frameworks to distinguish genuine therapeutic…
UK Health Security Agency Publishes Framework for Evidence-Based Public Health Evaluation
The United Kingdom Health Security Agency has released a comprehensive evaluation strategy establishing systematic assessment of public health interventions across…
WHO Africa Reports Progress on Electronic Disease Surveillance in May 2026 Bulletin
WHO AFRO released its May 2026 electronic surveillance bulletin, documenting eSURV and integrated surveillance system performance across 47 African member…
Trump Administration Derails Alcohol Research as Public Health Crisis Deepens
A STAT investigation reveals the Trump administration has downplayed alcohol's health risks and actively disrupted federal research and prevention efforts,…
Why Are We Losing Americans to Measles? Pennsylvania’s Third Death Exposes Vaccination Infrastructure Collapse
Pennsylvania's third measles-related death signals institutional failure in vaccination infrastructure and public health communication, not inevitable disease spread. Preventing further…
NEJM Retracts Landmark Avacopan Vasculitis Trial After Data Integrity Concerns
The New England Journal of Medicine has retracted a landmark 2021 trial on avacopan for ANCA-associated vasculitis following identification of…
Automated Genomic Reanalysis Tool Offers Rare Disease Diagnoses at Scale and Low Cost
Researchers have developed Talos, an open-source tool for automating reanalysis of genomic data from patients with rare genetic diseases, enabling…
Correction Published for ABBV-706 Phase 1 Trial in Small Cell Lung Cancer and Solid Tumors
Nature Medicine has published an author correction to the ABBV-706 phase 1 trial, a SEZ6-targeting antibody-drug conjugate for advanced small…